DrugPatentWatch concentrates deep knowledge on more than 6,400 small-molecule drugs and 2,300 generic ingredients from 1,700 branded and generic pharmaceutical companies and 700 suppliers, and more than 4,400 active and expired US patents and 74,000 international patents spanning 93 countries and regional patent offices.
Summary for Tradename: NEMBUTAL
Clinical Trials for: NEMBUTAL
Dexmedetomidine Versus Pentobarbital for Pediatric Procedural Sedation
Status: Withdrawn Condition: Sedation
Comparison of Effectiveness of Pentobarbital and Thiopental in Patients With Refractory Intracranial Hypertension
Status: Terminated Condition: Traumatic Brain Injury
Sedation for Brainstem Evoked Auditory Response (BEAR) Testing Using Intravenous Pentobarbital
Status: Enrolling by invitation Condition: Childrens 0 to 18 Years of Age Who Require Moderate Sedation
GHB Withdrawal Symptoms and Effectiveness of Treatment With Lorazepam Versus Pentobarbital - 1
Status: Terminated Condition: Sodium Oxybate; Substance-Related Disorders
Physiological, Behavioral and Subjective Effects of Drugs (GHB)
Status: Completed Condition: Sedative Abuse
Pharmacokinetics and Pharmacodynamics of Pentobarbital in Neonates, Infants, and Children Following Open Heart Surgery
Status: Terminated Condition: Cardiac Surgical Procedures
Treatment of Refractory Status Epilepticus
Status: Terminated Condition: Status Epilepticus
A Study To Evaluate The Abuse Potential Of Single Oral Doses Of Dimebon (Latrepirdine) In Healthy Recreational Polydrug Users
Status: Completed Condition: Alzheimer's Disease; Huntington's Disease
Tissue Specimen Collection for Study of Inherited Diseases Involving Non-muscle Gene Mutations
Status: Recruiting Condition: Inborn Genetic Diseases; Pentalogy of Cantrell
A Study to Assess the Abuse Potential of Hydrocodone Extended-Release Tablet in Recreational Opioid Users
Status: Completed Condition: Drug Abuse
Courtesy of ClinicalTrials.org
See more clinical trials for this drug
|Applicant||Tradename||Generic Name||Dosage||NDA||Approval Date||Type||RLD||Patent No.||Patent Expiration||Exclusivity Expiration|
|Elixir; Oral||083244||Approved prior to Jan 1, 1982||RX||Yes||<disabled>||<disabled>|
|Suppository; Rectal||083247||Jan 25, 1982||RX||Yes||<disabled>||<disabled>|
|Capsule; Oral||083245||Approved prior to Jan 1, 1982||RX||Yes||<disabled>||<disabled>|
|Capsule; Oral||084093||Approved prior to Jan 1, 1982||RX||Yes||<disabled>||<disabled>|
|The preview shows a limited data set. Complete access is available with a Subscription|
Export unavailable in trial.
Subscribe for complete access.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Copyright © 2002-2013 thinkBiotech LLC. ISSN: 2162-2639